The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Atosiban Accord 6.75 mg Solution for Injection in pre-filled syringe

6.75 milligram(s) Solution for injection in pre-filled syringe

Accord Healthcare Ireland Ltd.PA2315/105/002

Main Information

Trade NameAtosiban Accord 6.75 mg Solution for Injection in pre-filled syringe
Active SubstancesAtosiban
Strength6.75 milligram(s)
Dosage FormSolution for injection in pre-filled syringe
Licence HolderAccord Healthcare Ireland Ltd.
Licence NumberPA2315/105/002

Group Information

ATC CodeG02CX Other gynecologicals
G02CX01 atosiban

Status

Authorised/WithdrawnAuthorised
Licence Issued27/07/2018
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal products on “restricted” medical prescription, reserved for use in certain specialised areas (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back